Matches in SemOpenAlex for { <https://semopenalex.org/work/W2015783403> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W2015783403 abstract "At present, there is no reliable method for long-term treatment of severe pain from progressive systemic sclerosis (PSS) associated with Raynaud's phenomena leading to ischemia and ulcerations of the extremities. Long-term continuous intrathecal (IT) buprenorphine/bupivacaine analgesia was used in such a case.The patient was a 71-year-old woman in whom conservative treatment, including opioids, dorsal column stimulation, and epidural bupivacaine, had failed to provide satisfactory, long-term relief for her severe lower extremity pain. An 18-gauge Portex intrathecal catheter was inserted via the L4-L5 interspace. An infusion of 4.75 mg/mL bupivacaine and 0.015 mg/mL buprenorphine was started from a portable Pharmacia-Deltec (St. Paul, MN) pump at a rate of 0.1 mL/h with optional bolus doses of 0.1 mL, 2-4 times/h by patient controlled intrathecal analgesia. The rate was adjusted to give the patient satisfactory (80-100%) pain relief.The IT treatment was continued with 0.1 mL (approximately 0.5 mg/h bupivacaine) for most of the time (mean dose = 18.6 mg/d). This treatment gave the patient 90-100% pain relief, which subsequently improved the quality of her life. Nocturnal sleep duration increased from 2 hours before to 7-8 hours during the IT treatment. The treatment was complicated by transient post-dural puncture headache and further by meningitis, successfully treated with parenteral and intrathecal antibiotics. Every attempt to increase the IT bupivacaine to >20 mg/d led to transient urinary retention, paresthesia, and reduced motor strength in the lower extremities accompanied by gait disturbances. The IT treatment lasted for 861 days (of which 580 days were spent at home), until the patient's death, not related to the treatment.Intrathecal infusion of buprenorphine/bupivacaine provided satisfactory long-term pain relief in a patient with PSS-associated Raynaud's phenomena, skin ulcerations, and intractable ischemic pain." @default.
- W2015783403 created "2016-06-24" @default.
- W2015783403 creator A5023730423 @default.
- W2015783403 creator A5027551857 @default.
- W2015783403 creator A5044192075 @default.
- W2015783403 creator A5049202699 @default.
- W2015783403 date "1999-02-01" @default.
- W2015783403 modified "2023-09-25" @default.
- W2015783403 title "Progressive systemic sclerosis: Intrathecal pain management*1" @default.
- W2015783403 cites W1572441240 @default.
- W2015783403 cites W1987999003 @default.
- W2015783403 cites W2032861271 @default.
- W2015783403 cites W2034791229 @default.
- W2015783403 cites W2046868598 @default.
- W2015783403 cites W2063842454 @default.
- W2015783403 cites W2094041471 @default.
- W2015783403 cites W2102013706 @default.
- W2015783403 cites W2239759402 @default.
- W2015783403 cites W2412839628 @default.
- W2015783403 cites W2415885682 @default.
- W2015783403 cites W2434869474 @default.
- W2015783403 cites W2462609837 @default.
- W2015783403 cites W2531686102 @default.
- W2015783403 cites W3141695556 @default.
- W2015783403 doi "https://doi.org/10.1016/s1098-7339(99)90171-2" @default.
- W2015783403 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9952101" @default.
- W2015783403 hasPublicationYear "1999" @default.
- W2015783403 type Work @default.
- W2015783403 sameAs 2015783403 @default.
- W2015783403 citedByCount "6" @default.
- W2015783403 countsByYear W20157834032012 @default.
- W2015783403 countsByYear W20157834032018 @default.
- W2015783403 crossrefType "journal-article" @default.
- W2015783403 hasAuthorship W2015783403A5023730423 @default.
- W2015783403 hasAuthorship W2015783403A5027551857 @default.
- W2015783403 hasAuthorship W2015783403A5044192075 @default.
- W2015783403 hasAuthorship W2015783403A5049202699 @default.
- W2015783403 hasConcept C126322002 @default.
- W2015783403 hasConcept C141071460 @default.
- W2015783403 hasConcept C157820659 @default.
- W2015783403 hasConcept C170493617 @default.
- W2015783403 hasConcept C2778949969 @default.
- W2015783403 hasConcept C2781063702 @default.
- W2015783403 hasConcept C2781267111 @default.
- W2015783403 hasConcept C2781328992 @default.
- W2015783403 hasConcept C42219234 @default.
- W2015783403 hasConcept C43376680 @default.
- W2015783403 hasConcept C71924100 @default.
- W2015783403 hasConceptScore W2015783403C126322002 @default.
- W2015783403 hasConceptScore W2015783403C141071460 @default.
- W2015783403 hasConceptScore W2015783403C157820659 @default.
- W2015783403 hasConceptScore W2015783403C170493617 @default.
- W2015783403 hasConceptScore W2015783403C2778949969 @default.
- W2015783403 hasConceptScore W2015783403C2781063702 @default.
- W2015783403 hasConceptScore W2015783403C2781267111 @default.
- W2015783403 hasConceptScore W2015783403C2781328992 @default.
- W2015783403 hasConceptScore W2015783403C42219234 @default.
- W2015783403 hasConceptScore W2015783403C43376680 @default.
- W2015783403 hasConceptScore W2015783403C71924100 @default.
- W2015783403 hasLocation W20157834031 @default.
- W2015783403 hasLocation W20157834032 @default.
- W2015783403 hasOpenAccess W2015783403 @default.
- W2015783403 hasPrimaryLocation W20157834031 @default.
- W2015783403 hasRelatedWork W1981042065 @default.
- W2015783403 hasRelatedWork W1986113406 @default.
- W2015783403 hasRelatedWork W2401824817 @default.
- W2015783403 hasRelatedWork W2408042122 @default.
- W2015783403 hasRelatedWork W2415713126 @default.
- W2015783403 hasRelatedWork W2431594627 @default.
- W2015783403 hasRelatedWork W2460766827 @default.
- W2015783403 hasRelatedWork W2464318107 @default.
- W2015783403 hasRelatedWork W3021553848 @default.
- W2015783403 hasRelatedWork W3088950288 @default.
- W2015783403 isParatext "false" @default.
- W2015783403 isRetracted "false" @default.
- W2015783403 magId "2015783403" @default.
- W2015783403 workType "article" @default.